D3R on MCs also may be involved in superoxide dismutase (SOD)-mediated pathogenesis of RA, and it may inhibit SOD production by negatively modulating TLR4 signaling on MCs in RA patients [61]. The gene discussed is TLR4; the disease is rheumatoid arthritis.